🟢 Protara Therapeutics is trading 6% up in pre-market with no clear catalyst identified

Protara Therapeutics is trading 6% up now at $4.09 in pre-market, with no clear company-specific catalyst identified for September 1, 2026.

• The latest located company announcement was its August 11, 2026 second-quarter financial update; no newer overnight press release or SEC filing was found.
• The S&P 500 was down 0.38% and Nasdaq Composite down 0.65%, so macro sentiment does not clearly explain the upward move.
• Reason remains unconfirmed.